Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03463980 · ClinicalTrials.gov registry record · NA

Compassion Meditation and ReliefLink App for Suicidal, Low-Income, African Americans

A NA study, sponsored by Emory University.

Terminated
Registry status
NA
Development phase
456
Enrollment target

NCT03463980: Clinical Trial NA study, sponsored by Emory University.

NCT03463980 is a NA study that was terminated before completion, run by Emory University. The registered enrollment target is 456 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03463980, a NA study, was terminated before completion, sponsored by Emory University.

TERMINATED
Registry status
NA
Development phase
456 participants
Enrollment target

Study Summary

The purpose of this study is to conduct a pilot randomized controlled trial (RCT) with low-income, suicidal African American women and men that compares the relative effectiveness of compassion meditation (CM) versus a support group (SG) .

Primary Outcome

The BSS is a self-report 19-item scale preceded by five screening items. The BSS and its screening items are intended to assess a patient's thoughts, plans and intent to commit suicide. All 24 items are rated on a three-point scale (0 to 2) total scores could range from 0 to 48. No specific cut-off scores exist to classify severity or guide patient management. Increasing scores reflect greater suicide risk, and any positive response merits investigation.

Interventions

  • BEHAVIORAL Compassion meditation (CM)
  • BEHAVIORAL Support group (SG)

Trial Details

FieldValue
Enrollment Target 456 participants
Start Date 2010-05-13
Est. Completion 2021-10-22
Phase NA
Emory University

1,208 total trials

Why NCT03463980 stopped before completion

NCT03463980 is an interventional study that assigns participants to a tested intervention. The registered 456 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower).

The record links to 0 conditions, and to 2 interventions - of which Compassion meditation (CM) is the first listed.

NCT03463980 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03463980 about?

NCT03463980 is a clinical study titled "Compassion Meditation and ReliefLink App for Suicidal, Low-Income, African Americans". The purpose of this study is to conduct a pilot randomized controlled trial (RCT) with low-income, suicidal African American women and men that compares the relative effectiveness of compassion meditation (CM) versus a support group (SG) .

What is the current status of trial NCT03463980?

This trial is currently terminated. It is a NA study. The enrollment target is 456 participants. The study started on 2010-05-13. Estimated completion is 2021-10-22.

What interventions are being tested in trial NCT03463980?

The interventions under investigation include: Compassion meditation (CM) (BEHAVIORAL), Support group (SG) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03463980?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03463980's enrollment target sits among peer trials

456 224th of 2000 higher than 1,777 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04462302 · 456 participants · NA

    An Internet-based Program to Help Cancer Survivors Manage Pain

  • NCT05820919 · 456 participants · NA

    Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase

  • NCT06254612 · 456 participants · Phase 2

    A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder

  • NCT06457841 · 456 participants · NA

    Stress and Resilience

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03463980, the US trial registry maintained by the National Library of Medicine. NCT03463980 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.